MM is highly dependent on IL-6 during certain stages of disease progression (84) and increased levels of the highly inflammatory cytokine IL-17 or T helper 17 cells in PBMCs and the bone marrow microenvironment correlates with exacerbated disease (85). The gene discussed is IL6; the disease is Miyoshi myopathy.